Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001763056 | SCV001989153 | uncertain significance | not provided | 2019-08-09 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004601522 | SCV005101979 | uncertain significance | not specified | 2024-03-16 | criteria provided, single submitter | clinical testing | The c.11507C>T (p.P3836L) alteration is located in exon 66 (coding exon 66) of the KIAA1109 gene. This alteration results from a C to T substitution at nucleotide position 11507, causing the proline (P) at amino acid position 3836 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |